Company Profile

Ictero Medical Inc
Profile last edited on: 9/12/22      CAGE: 85KQ4      UEI: DMR3CEJLQ5J6

Business Identifier: Novel cryoablation system to treat high-risk patients with gallstone disease
Year Founded
2018
First Award
2020
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2450 Holcombe Boulevard Suite 88
Houston, TX 77021
   (832) 282-0148
   N/A
   www.icteromedical.com
Location: Single
Congr. District: 18
County: Harris

Public Profile

Designated an Alumni of the JLabs facility in Houston TX., Ictero Medical is organized around development and use of a catheter-based, cryoablation system designed to treat gallstone disease. Designated the Cholesafe System systems, the developed approach is offered as a minimally invasive treatment to treat gallstone disease: usefully understood as a catheter-based, cryoablation system that provides definitive treatment for gallstone disease. Requiring only minimal local anesthesia, the approach allows the developed system to be used in the interventional radiology suite - effectively defunctionalizing the gallbladder without having to remove it, providing the benefits of surgery but without the risk.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Matthew Nojoomi -- CEO, Co-Founder

  Kovi Bessoff -- Clinical Research Lead, Co-Founder

  Raymond Kirk -- CMO

  David Waters -- COO, Co-Founder

Company News

There are no news available.